Gastroparesis Drugs for Medical Implants Market 2028 By Drug Class, Disease Type, End User and Geography | The Insight Partners

report image

Gastroparesis Drugs for Medical Implants Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Drug Class (Prokinetic Agents, Antiemetic Agents, Botulinum Toxin Injections); Disease Type (Diabetic Gastroparesis, Idiopathic Gastroparesis, Post-surgical Gastroparesis, Others); End User (Hospitals, Pharmacies, Clinics, E-commerce) and Geography

Report Code: TIPRE00004764 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming


Gastroparesis is a condition that occurs due to inappropriate working of digestive system and leads to improper functioning of the stomach. Gastroparesis is caused due to diabetes, medications such as antidepressants, injuries to the vagus nerve that controls the digestive system and others. This condition can lead to the growth of bacteria in stomach. The Gastroparesis is a chronic disease that lasts for long duration and have no commercially available treatment options for its cure.


The global gastroparesis drugs market is expected to grow due to increase in geriatric population, rise in number of surgeries leading to gastroparesis, increase in usage of drugs for vomiting and nausea, increase in the prevalence of diabetes and others. On the other hand, increase in funding for improving healthcare infrastructure, and emergence of new local players within the developing economies are expected to provide opportunities in market growth.


The "Global Gastroparesis Drugs Market Analysis to 2028" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of gastroparesis drugs market with detailed market segmentation by drug class, disease type, end user and geography. The global gastroparesis drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading gastroparesis drugs market players and offers key trends and opportunities in the market.


The global gastroparesis drugs market is segmented on the basis of drug class, disease type, and end user Based on drug class, the market is segmented as prokinetic agents, antiemetic agents, and botulinum toxin injections. Based on disease type the market is segmented as diabetic gastroparesis, idiopathic gastroparesis, post-surgical gastroparesis, others. On the basis of end user the gastroparesis drugs market is segmented into hospitals, pharmacies, clinics, and e-commerce.

Get more information on this report :


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global gastroparesis drugs market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The gastroparesis drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting gastroparesis drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the gastroparesis drugs market in these regions.

Get more information on this report :


The reports cover key developments in the gastroparesis drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from gastroparesis drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for gastroparesis drugs in the global market. Below mentioned is the list of few companies engaged in the gastroparesis drugs market.

The report also includes the profiles of key gastroparesis drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Abbott
  • AstraZeneca Plc.
  • Cadila Pharmaceuticals
  • ETX Pharma, Inc.
  • Evoke Pharma
  • GlaxoSmithKline Plc.
  • Neurogastrx, Inc.
  • Bausch Health Companies Inc.
  • Theravance Biopharma
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Get more information on this report :

The List of Companies

2. Abbott
3. AstraZeneca Plc.
4. Cadila Pharmaceuticals
5. ETX Pharma, Inc.
6. Evoke Pharma
7. GlaxoSmithKline Plc.
8. Neurogastrx, Inc.
9. Bausch Health Companies Inc.
10. Theravance Biopharma.
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount